Sale of drugs producer Polfa Kutno expected to generate zl.334 million

At least three international companies are interested in purchasing Polish p harmaceutics company Polfa Kutno. Although the identities of the three poten tial buyers have not been revealed, it is known that a new investor will ann ounce a bid for 100% of Polfa Kutno shares. Ryszard Wojtkowski, chairman of the Polfa Kutno supervisory board and representative of Enterprise Investors , which holds 70% of the drugs manufacturer, told Puls Biznesu it is too ear ly to say when the entire process would be finalized and which of the intere sted companies would go through to the next stage of negotiations. However, the investors have until December 10 to assess the company's financial situa tion. In recent weeks, Polfa Kutno's shares have been trading at around zl.1 20 each on the Warsaw Stock Exchange (WSE), a price that would value the 100 % stake at zl.334 million. (Puls Biznesu, p. 9) M.T.K.